CDC Revises Fungal Meningitis Treatment Guidance

The Centers for Disease Control and Prevention has revised treatment guidance related to the fungal meningitis outbreak about six months ago.

Advertisement

The outbreak stemmed from contaminated medication from the New England Compounding Center in Framingham, Mass.

Click here to read the full story on the revised guidance in Becker’s ASC Review.

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.